Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Joerg Herrmann MD
Joerg Herrmann MD Associate Editor
Peter Libby MD
Peter Libby MD Advisory Board
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
See All Experts
featured
Published in Cardiology

Journal Scan / Research · October 11, 2017

Similar Benefits From Below-Target and Target Dose Enalapril in Patients With Heart Failure

European Journal of Heart Failure

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI

European Journal of Heart Failure
Similar Clinical Benefits From Below-Target and Target Dose Enalapril in Patients With Heart Failure in the SOLVD Treatment Trial
Eur. J. Heart Fail 2017 Oct 05;[EPub Ahead of Print], PH Lam, DJ Dooley, GC Fonarow, J Butler, DL Bhatt, GS Filippatos, P Deedwania, DE Forman, M White, RD Fletcher, C Arundel, MR Blackman, C Adamopoulos, IE Kanonidis, IB Aban, K Patel, WS Aronow, RM Allman, SD Anker, B Pitt, A Ahmed

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated